Unlocking Therapeutic Potential: Enhanced shRNA Delivery with Tat Peptide in the Human Respiratory Syncytial Virus Treatment.

MLA

Amiri Zadeh Fard, Saeid, et al. “Unlocking Therapeutic Potential: Enhanced ShRNA Delivery with Tat Peptide in the Human Respiratory Syncytial Virus Treatment.” Advanced Pharmaceutical Bulletin, vol. 14, no. 3, July 2024, pp. 696–704. EBSCOhost, https://doi.org/10.34172/apb.2024.045.

APA

Amiri Zadeh Fard, S., Abuei, H., Behzad Behbahani, A., Rafiei Dehbidi, G., Zare, F., Nejabat, M., Safarpour, A., & Farhadi, A. (2024). Unlocking Therapeutic Potential: Enhanced shRNA Delivery with Tat Peptide in the Human Respiratory Syncytial Virus Treatment. Advanced Pharmaceutical Bulletin, 14(3), 696–704. https://doi.org/10.34172/apb.2024.045

Chicago

Amiri Zadeh Fard, Saeid, Haniyeh Abuei, Abbas Behzad Behbahani, Gholamreza Rafiei Dehbidi, Farahnaz Zare, Maryam Nejabat, Alireza Safarpour, and Ali Farhadi. 2024. “Unlocking Therapeutic Potential: Enhanced ShRNA Delivery with Tat Peptide in the Human Respiratory Syncytial Virus Treatment.” Advanced Pharmaceutical Bulletin 14 (3): 696–704. doi:10.34172/apb.2024.045.